Our lab receives funding from various sources that include the National Institutes of Health, philanthropic organizations, institutional organizations, and individual gifts. A list of current and past grants where we direct or collaborate on research projects is shown below.
National Institutes of Health
DOE BER 100651
Molecular design and analysis to inform therapeutics related to COVID-19
4/27/2020 – 9/30/2021
NIH R01 EY031360
Improving rigor and reproducibility in adaptive optics ophthalmoscopy
1/01/20-6/30/24
NIH R01 EY031952
Proteomic Biomarkers of Intraocular Infection
8/01/20-7/31/24
NIH R01 EY030151
Inflammatory Gene Transcription in the Retina
1/01/20-12/31/24
NIH P30 EY026877
Stanford Vision Research Core
9/30/17-6/30/22
NIH R01 NS-98950
Exploring novel epilepsy pathways
5/15/16-2/28/21
NIH R01 AR59703
Genetic and immunologic etiology of chronic recurrent multifocal osteomylitis (CRMO)
9/28/15-8/31/20
NIH R01 EY-26682
Mechanistic studies on regenerative medicine approaches to childhood blindness
4/1/16-03/31/20
NIH R01 EY-24698
Gene silencing and gene editing in phototransduction
9/1/15-6/30/19
NIH R01 EY-24665
Structure and function of Calpain-5
12/1/14-11/30/19
NIH R01 EY-25225
Mechanism-based therapies for photoreceptor degeneration
5/1/15-4/30/19
NIH R21 AG-50437
Evaluating GWAS AMD candidate loci by gene editing in human IPS cells
4/15/15-3/31/18
NIH K08 EY020530
Molecular Genetics of Dominant Neovascular Inflammatory Vitreoretinopathy
02/01/11 – 01/31/16
Training Grants
NIH T32 (Mentor)
Stanford Vision Research Training Program: Drug Design
7/2022 - 8/2023
Major grant Vice Provost of Undergraduate Education (Mentor)
Drug implant development
7/2022-9/2022
Bright Focus Macular Degeneration Award (Mentor)
4/2021-5/2023
VitreoRetinal Surgery Foundation Research Award (Mentor)
Endophthalmitis Proteomics
11/2020 - 5/2021
Bio-X Undergraduate Summer Research Program (Mentor)
Proteomics of Vitreoretinal Disease
06/2020 - 09/2020
NIH T32 (Mentor)
Stanford Vision Research Training Program: Drug Design
3/2020 - 3/2021
ChEM-H Undergraduate Scholars Program (Mentor)
01/2020 - 09/2020
NIH F30 EY027986 (Mentor)
Structure-function studies of Calpain-5 in hereditary uveitis
03/2018 - 03/2022
NIH-F31 EY026789-02 (Mentor)
CAPN5 –PDGF Signaling in Vitreoretinopathy
04/15/2016-03/31/2021
NIH 5F32EY022280 (Mentor)
Molecular Mechanisms of SOD3 and Oxidative Stress in Diabetic Vitreoretinopathy
5/2012-5/2015
Foundations
Doris Duke Charitable Foundation
Data Sharing Eye Proteomics
1/2020 - 1/2021
Research to Prevent Blindness
Research Collaborations
9/2018 - 8/2022
Doris Duke Charitable Foundation
Clinical Scientist Development Award
Molecular Genetic Mechanisms of Calpain-5 Autoimmunity
7/2013 - 6/2017
Research to Prevent Blindness.
Molecular Genetics of ADNIV
9/2011 – 10/2016
Bright Focus
Cytokine Signaling in the Foveal Choroid in AMD
7/2011 – 6/2013
Fight for Sight
Molecular Genetics of Retinal Detachment
7/2009 – 6/2012
A.P. Giannini Foundation
7/2003 – 6/2005
Institutional
Stanford ChEM-H COVID-19 Response: Drug and Vaccine Prototyping
Inhibition of host serine proteases
6/2020 - 7/2021
Stanford Alliance for Innovative Medicines
Target-driven Drug Discovery
1/2019 - 12/2019
ChEM-H Testing Molecular Hypotheses in Human Subjects
Vitreous Proteases
3/2018 - 2/2019
